Click 
to remove filters
The Optica Clulow Group, which owns a string of opticians across England, is reviewing its consumer and trade PR. The account is expected to carry a six-figure fee and at least two agencies are known to be pitching for it.
Genetically-modified (GM) seeds and food continued to receive attention this week. Raisio, the Finnish supplier of Benecol, the margarine that reduces cholesterol, can go straight to a European launch because it doesn t need EU approval. EU-imposed tests must be conducted on Monsanto s GM seeds, however,...
People afflicted by social phobia or social anxiety disorder aren t just shy. They ll totally avoid situations many of us take for granted, regardless of the consequences to their job, relationships or their health.
Celanese, a subsidiary of German chemicals giant Hoechst, is seeking a PR agency to handle corporate and business-to-business PR as it prepares for flotation. The company does not currently employ an agency. The brief will initially focus on PR in Germany. Celanese is the second largest company within...
Pfizer did not refer to Viagra, its EC-licensed candidate for NHS prescription, as offering life enhancement. It concentrated on the two million couples suffering impotence, arguing that the pounds 50 million cost of Viagra on the NHS would be in line with existing treatment.
A majority of pharmaceutical companies make use of in-depth evaluation techniques and are turning their backs on advertising value equivalents (AVEs) according to a PR Week straw poll of ten in-house PR departments.
The Bioindustry Association, the trade body for small and medium-sized biological sciences companies, has appointed its first public affairs director, Aisling Burnand.
The Department of Health (DoH) launched a new campaign last week, aimed at curbing the increase in antibiotic resistant bacteria.
The Boots Company is reviewing its public affairs account which has been held by GJW for the past five years.
Pharmaceutical giant Pfizer has appointed EMC Euro PR to handle PR for the launch of its new migraine drug, Eletriptan, in Europe and the US.
